Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimseg-P1 Tablet SR

Prescription Icon
Prescription Required

Marketer

SAG Health Science Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimseg-P1 Tablet SR

DiaBeta-Comp SR tablets combine medications to effectively manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin use, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for DiaBeta-Comp SR. Taking it with food mitigates potential stomach discomfort. If a dose is missed, take it promptly; however, near the next scheduled dose, omit the missed one and resume the usual schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals increases the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should also seek medical counsel before use. Your doctor will assess kidney function before prescribing. Limit alcohol consumption, as it may amplify the risk of side effects.

Uses of Glimseg-P1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimseg-P1 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimseg-P1 SR tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimseg-P1 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimseg-P1 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimseg-P1 SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Glimseg-P1 Tablet SR works:

Glimseg-P1 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood sugar management when single or dual-agent treatments prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimseg-P1 SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimseg-P1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Glimseg-P1 tablets may pose a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk, with possible adverse effects on the nursing child.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Exercise caution when administering Glimseg-P1 SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Glimseg-P1 SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glimseg-P1 Tablet SR; dosage modification may be necessary. Consult a physician for guidance. Glimseg-P1 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimseg-P1 Tablet SR :

Should you forget a dose of Glimseg-P1 Tablet SR, take it immediately if you remember. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimseg-P1 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes medication

FAQs on Glimseg-P1 Tablet SR

Consuming alcohol while taking Glimseg-P1 Tablet SR is unsafe. Alcohol can lead to dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Consult your doctor before taking Glimseg-P1 Tablet SR if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and of all medications, vitamins, and herbal supplements you are taking, including over-the-counter drugs.
Glimseg-P1 SR tablets, containing metformin, can lead to vitamin B12 deficiency with prolonged use due to impaired vitamin B12 absorption in the stomach.
Glimseg-P1 SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a quick-sugar source, such as candy or chocolate.
Store this medication in its original, tightly sealed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimseg-P1 Tablet SR
58
MRP 71
18% off